 |
CD39+CD8+ T Cells as a Marker for Diagnosis and Prognosis of ESCC
A research team from China investigated the role of CD39+CD8+ T cells in the diagnosis and prognosis of esophageal squamous cell carcinoma (ESCC), based on the potential inhibitory effect of CD39 in cancers. After mIF staining of the slides with patient tissue samples, the slides were acquired using TissueFAXS platform. As a result, the team proposed CD39+CD8+ T cells as a new molecular marker for the diagnosis and prognosis of ESCC.
|